Skip to main content
Equibles

SLGL · Sol-Gel Technologies Ltd. · Metrics

Track SLGL — free

Use SLGL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SLGL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$65.94 -0.85 (-1.27%) At close · Sep 11
Rebalance outlook locked
Market Cap
$215.89M
Shares
3.27M

SLGL metrics

48 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$65.94
Market cap
$215.89M

Price action

20 metrics
Price change (1W)
-5.1%
Price change (30D)
-22.1%
Price change (3M)
-10.2%
Price change (6M)
-21.5%
Price change (YTD)
+56.5%
Price change (1Y)
+173.8%
Trailing year
Price change (5Y)
—
52-week high
$97.97
52-week low
$23.98
Change from 52-week high
-32.7%
Change from 52-week low
+175.0%
Annualized volatility
89.2%
Annualized volatility (3M)
68.4%
Beta
0.9
RSI (14D)
34.0
Price vs SMA 50
-15.4%
Price vs SMA 200
-5.8%
Avg volume (3M)
51,128
Relative volume
0.5
Average dollar volume
$3.95M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
3.27M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
9.5
reciprocal yield 10.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-38.9%
Trailing 12 months
Net margin
-31.6%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$8.19

Growth

11 metrics
Revenue growth YoY
+217.7%
Year over year
Net income growth YoY
+487.6%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+487.3%
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
+70.9%
Revenue CAGR (5Y)
+17.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-26.9%
Return on assets
-20.5%
Debt / equity
—
Current ratio
4.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
4.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$11.03M
Total assets
$29.92M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
24
13F filer change QoQ
+3
Institutional ownership
40.4%

Short interest

3 metrics
Short interest
2.3%
Latest settlement · 1.1 days to cover
Days to cover
1.1d
Short-squeeze score
45 / 100

Insider activity

2 metrics
Net insider buying (90D)
$3.95M
Insider-sentiment score
91 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1684693 CUSIP M8694L137 13F (30d) 12 filings 12 filers Visit website Investor relations